Angelique Chanal

Title: Angelique Chanal: Innovator in Isoprenoid Research

Introduction

Angelique Chanal is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the area of isoprenoid research. With a total of 2 patents, her work focuses on genetically modified host cells and methods to enhance microbial tolerance to specific compounds.

Latest Patents

Angelique Chanal's latest patents include innovative technologies aimed at reducing isoprenoid precursors and isoprenoids through the use of geranylgeranyl reductase. The first patent provides a genetically modified host cell capable of reducing one or more isoprenoids or their precursors. This host cell comprises one or more geranylgeranyl reductases (GGRs) or polypeptides with a significant identity to GGR sequences, enabling the catalysis of GGR reactions. The second patent focuses on methods for improving microbial tolerance to alpha olefin compounds, along with host cells that exhibit increased tolerance to these compounds. This advancement allows for the production of alpha olefin compounds using the modified host cells.

Career Highlights

Throughout her career, Angelique has worked with esteemed organizations such as the University of California and Total Marketing Services. Her experience in these institutions has allowed her to develop her expertise in biotechnology and contribute to groundbreaking research.

Collaborations

Angelique has collaborated with notable professionals in her field, including Florence Mingardon and Aindrila Mukhopadhyay. These partnerships have further enriched her research and innovation efforts.

Conclusion

Angelique Chanal is a remarkable inventor whose work in isoprenoid research has led to significant advancements in biotechnology. Her patents and collaborations reflect her dedication to innovation and her impact on the scientific community.